Differential immunometabolic phenotype in Th1 and Th2 dominant mouse strains in response to high-fat feeding

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Jovicic, Nemanja ^a   Jeftic, Ilija ^a   Jovanovic, Ivan ^a   Radosavljevic, Gordana ^a   Arsenijevic, Nebojsa ^a   Lukic, Miodrag L ^a   Pejnovic, Nada ^a  

^a University of Kragujevac Medical Faculty   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE;

ADVERSE EFFECTS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; INTRAABDOMINAL FAT; LIPID DIET; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; PHENOTYPE; SPECIES DIFFERENCE; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; DIET, HIGH-FAT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FLOW CYTOMETRY; GLUCOSE; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTRA-ABDOMINAL FAT; LIVER CIRRHOSIS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; SPECIES SPECIFICITY; TH1 CELLS; TH2 CELLS;

EID: 84942044733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134089     Document Type: Article

References (56)

1. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011; 332:1519-1523. doi:10.1126/science.1204265 PMID: 21700865.
2. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012; 482:179-185. doi:10.1038/nature10809 PMID: 22297845.
3. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007/04/28 ed. 2007; 13:1579- 1584. PMID: 17461452.
4. Grarup N, Sandholt CH, Hansen T, Pedersen O. Genetic susceptibility to type 2 diabetes and obesity: From genome-wide association studies to rare variants and beyond. Diabetologia. 2014/05/27 ed. 2014; 57:1528-1541. doi:10.1007/s00125-014-3270-4 PMID: 24859358.
5. Kozlitina J, Smagris E, Stender S, Nordestgaard BG, Zhou HH, Tybjaerg-Hansen A, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014/02/18 ed. 2014; 46:352-356. doi:10.1038/ng.2901 PMID: 24531328.
6. Lin YC, Chang PF, Chang MH, Ni YH. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. Am J Clin Nutr. 2014/01/31 ed. 2014; 99:869-874. doi:10.3945/ajcn.113.079749 PMID: 24477042.
7. Choi S, Diehl AM. Role of inflammation in nonalcoholic steatohepatitis. Curr Opin Gastroenterol. 2005/10/13 ed. 2005; 21:702-707. PMID: 16220049.
8. Li Z, Soloski MJ, Diehl AM. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology. 2005/09/22 ed. 2005; 42:880-885. doi:10.1002/hep.20826 PMID: 16175608.
9. Mouralidarane A, Soeda J, Visconti-Pugmire C, Samuelsson AM, Pombo J, Maragkoudaki X, et al. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology. 2013/01/15 ed. 2013; 58:128-138. doi:10.1002/hep.26248 PMID: 23315950.
10. Hayashi H, Sakai T. Animal models for the study of liver fibrosis: new insights from knockout mouse models. Am J Physiol Gastrointest Liver Physiol. 2011/02/26 ed. 2011; 300:G729-38. doi:10.1152/ajpgi.00013.2011PMID: 21350186.
11. Farrell GC, Mridha AR, Yeh MM, Arsov T, Van Rooyen DM, Brooling J, et al. Strain dependence of dietinduced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. Liver Int. 2014; 34:1084-93. doi:10.1111/liv.12335 PMID: 24107103.
12. Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG, et al. Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes. 2013; 62:1932-1944. doi:10.2337/db12-0222 PMID: 23349493.
13. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med. 1989/01/01 ed. 1989; 169:59-72. PMID: 2521244.
14. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med. 1995/02/01 ed. 1995; 181:713-721. PMID: 7836924.
15. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000/06/08 ed. 2000; 164:6166-6173. PMID: 10843666.
16. Stewart D, Fulton WB, Wilson C, Monitto CL, Paidas CN, Reeves RH, et al. Genetic contribution to the septic response in a mouse model. Shock. 2002/10/24 ed. 2002; 18:342-347. PMID: 12392278.
17. Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A. Innate Immune Response in Th1- And Th2- Dominant Mouse Strains. Shock. 2004; 22:460-466. doi:10.1097/01.shk.0000142249.08135.e9 PMID: 15489639.
18. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007/01/04 ed. 2007; 117:175-184. doi:10.1172/jci29881 PMID: 17200717.
19. Stefanovic-Racic M, Yang X, Turner MS, Mantell BS, Stolz DB, Sumpter TL, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes. 2012/08/02 ed. 2012; 61:2330-2339. doi:10.2337/db11-1523 PMID: 22851575.
20. Milovanovic M, Volarevic V, Ljujic B, Radosavljevic G, Jovanovic I, Arsenijevic N, et al. Deletion of IL- 33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype. PLoS One. 2012; 7:1-13. doi:10.1371/journal.pone.0045225.
21. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, et al. Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol. 2011/06/28 ed. 2012; 56:26-33. doi:10.1016/j.jhep.2011.03.022 PMID: 21703183.
22. Zdravkovic N, Shahin A, Arsenijevic N, Lukic ML, Mensah-Brown EP. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin. Mol Immunol. 2009/04/10 ed. 2009; 47:28-36. doi:10.1016/j.molimm.2008.12.023 PMID: 19356801.
23. Junqueira LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. Kluwer Academic Publishers; 1979; 11:447-455. doi:10.1007/BF01002772 PMID: 91593.
24. Hadi AM, Mouchaers KT, Schalij I, Grunberg K, Meijer GA, Vonk-Noordegraaf A, et al. Rapid quantification of myocardial fibrosis: A new macro-based automated analysis. Anal Cell Pathol (Amst). 2010/10/28 ed. 2010; 33:257-269. doi:10.3233/acp-clo-2010-0548.
25. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001/09/04 ed. 2001; 23:291-299. PMID: 11531144.
26. Deutsch MJ, Schriever SC, Roscher AA, Ensenauer R. Digital image analysis approach for lipid droplet size quantitation of Oil Red O-stained cultured cells. Anal Biochem. 2013/10/15 ed. 2014; 445:87-89. doi:10.1016/j.ab.2013.10.001 PMID: 24120410.
27. Juluri R, Vuppalanchi R, Olson J, Unalp A, Van Natta ML, Cummings OW, et al. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease. J Clin Gastroenterol. 2010/05/28 ed. 2011; 45:55-58. doi:10.1097/MCG.0b013e3181dd1348 PMID: 20505526.
28. Foster B, Prussin C, Liu F, Whitmire JK, Whitton JL. Detection of intracellular cytokines by flow cytometry. Curr Protoc Immunol. 2008/04/25 ed. 2007;Chapter 6:Unit 6.24. doi:10.1002/0471142735.im0624s78.
29. Saksida T, Nikolic I, Vujicic M, Nilsson UJ, Leffler H, Lukic ML, et al. Galectin-3 deficiency protects pancreatic islet cells from cytokine-triggered apoptosis in vitro. J Cell Physiol. 2013; 228:1568-1576. doi:10.1002/jcp.24318 PMID: 23280610.
30. Pinchuk LM, Filipov NM. Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice. Immun Ageing. 2008/02/13 ed. 2008; 5:1. doi:10.1186/1742-4933-5-1 PMID: 18267021.
31. Groom JR, Luster AD. CXCR3 in T cell function. Exp Cell Res. 2011/03/08 ed. 2011; 317:620-631. doi:10.1016/j.yexcr.2010.12.017 PMID: 21376175.
32. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. The American Society for Clinical Investigation; 1998; 101:746-754. doi:10.1172/JCI1422 PMID: 9466968.
33. Lumeng CN, Maillard I, Saltiel AR. T-ing up inflammation in fat. Nat Med. Nature Publishing Group; 2009; 15:846-847. Available: http://dx.doi.org/10.1038/nm0809-846 doi: 10.1038/nm0809-846 PMID: 19661987.
34. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: A role for adaptive immunity in obesity. Circ Res. 2008/07/29 ed. 2008; 103:467-476. doi:10.1161/circresaha.108.177105 PMID: 18658050.
35. Stolarczyk E, Lord GM, Howard JK. The immune cell transcription factor T-bet. Adipocyte. Taylor & Francis; 2014; 3:58-62. doi:10.4161/adip.26220 PMID: 24575371.
36. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med. Nature Publishing Group; 2009; 15:921-929. http://www.nature.com/nm/journal/v15/n8/suppinfo/nm.2001-S1.html doi: 10.1038/nm.2001 PMID: 19633657.
37. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. The biology of white adipocyte proliferation. Obes Rev. 2002/07/18 ed. 2001; 2:239-254. PMID: 12119995.
38. Herberg L, DoppenW, Major E, Gries FA. Dietary-induced hypertrophic-hyperplastic obesity in mice. J Lipid Res. 1974/11/01 ed. 1974; 15:580-585. PMID: 4430881.
39. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, et al. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol. Public Library of Science; 2009; 5:e1000324. doi:10.1371/journal.pcbi.1000324 PMID: 19325873.
40. Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K. Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL/6J and BALB/cA mice. Exp Anim. 2007/07/31 ed. 2007; 56:263-272. PMID: 17660680.
41. Nishikawa S, Doi K, Nakayama H, Uetsuka K. The effect of fasting on hepatic lipid accumulation and transcriptional regulation of lipid metabolism differs between C57BL/6J and BALB/cA mice fed a highfat diet. Toxicol Pathol. 2008/09/25 ed. 2008; 36:850-857. doi:10.1177/0192623308323920 PMID: 18812581.
42. Nishikawa S, Sugimoto J, Okada M, Sakairi T, Takagi S. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol. 2012; 40:71-82. doi:10.1177/0192623311422078 PMID: 22105644.
43. Montgomery MK, Hallahan NL, Brown SH, Liu M, Mitchell TW, Cooney GJ, et al. Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia. 2013; 56:1129-39. doi:10.1007/s00125-013-2846-8 PMID: 23423668.
44. Fernandez I, Pena A, Del Teso N, Perez V, Rodriguez-Cuesta J. Clinical biochemistry parameters in C57BL/6J mice after blood collection from the submandibular vein and retroorbital plexus. J Am Assoc Lab Anim Sci. 2010/04/01 ed. 2010; 49:202-206. PMID: 20353696.
45. Lin X, Yue P, Chen Z, Schonfeld G. Hepatic triglyceride contents are genetically determined in mice: results of a strain survey. Am J Physiol Gastrointest Liver Physiol. 2004/12/14 ed. 2005; 288:G1179- 89. doi:10.1152/ajpgi.00411.2004 PMID: 15591160.
46. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 2000/11/23 ed. 2000; 14:2819-2830. PMID: 11090130.
47. Yoshikawa T, Shimano H, Amemiya-Kudo M, Yahagi N, Hasty AH, Matsuzaka T, et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter. Mol Cell Biol. 2001/04/05 ed. 2001; 21:2991-3000. doi:10.1128/mcb.21.9.2991-3000.2001 PMID: 11287605.
48. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. Elsevier; 2012; 15:635-645. doi:10.1016/j.cmet.2012.04.001 PMID: 22560216.
49. Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011; 300:G697-G702. doi:10.1152/ajpgi.00426.2010 PMID: 21350183.
50. Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol. 2006/01/27 ed. 2006; 87:1-16. doi:10.1111/j.0959-9673.2006.00465.x PMID: 16436109.
51. Bonniaud P, Martin G, Margetts PJ, Ask K, Robertson J, Gauldie J, et al. Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" Balb/c mouse lungs. Am J Respir Cell Mol Biol. 2004; 31:510-516. doi:10.1165/rcmb.2004-0158OC PMID: 15256388.
52. Walkin L, Herrick SE, Summers A, Brenchley PE, Hoff CM, Korstanje R, et al. The role of mouse strain differences in the susceptibility to fibrosis: A systematic review. Fibrogenesis Tissue Repair. Fibrogenesis & Tissue Repair; 2013; 6:18. doi:10.1186/1755-1536-6-18 PMID: 24294831.
53. De Minicis S, Svegliati-Baroni G. Fibrogenesis in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol. 2011/04/12 ed. 2011; 5:179-187. doi:10.1586/egh.11.28 PMID: 21476913.
54. Gadd VL, Skoien R, Powell EE, Fagan KJ, Winterford C, Horsfall L, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2013/11/21 ed. 2014; 59:1393-1405. doi:10.1002/hep.26937 PMID: 24254368.
55. Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Int J Clin Exp Pathol. 2013; 6:2683-2696. PMID: 24294355.
56. Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis. 2005/04/22 ed. 2005; 37:349-356. doi:10.1016/j.dld.2004.11.009 PMID: 15843085.